OLPRUVA is a Oral Kit in the Human Prescription Drug category. It is labeled and distributed by Acer Therapeutics Inc.. The primary component is .
| Product ID | 72542-500_f3b1222e-c8f1-46a8-b0d6-9f57107f6be1 |
| NDC | 72542-500 |
| Product Type | Human Prescription Drug |
| Proprietary Name | OLPRUVA |
| Generic Name | Sodium Phenylbutyrate |
| Dosage Form | Kit |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-12-22 |
| Marketing Category | NDA / |
| Application Number | NDA214860 |
| Labeler Name | Acer Therapeutics Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2022-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 72542-200 | OLPRUVA | sodium phenylbutyrate |
| 72542-300 | OLPRUVA | sodium phenylbutyrate |
| 72542-400 | OLPRUVA | sodium phenylbutyrate |
| 72542-500 | OLPRUVA | sodium phenylbutyrate |
| 72542-600 | OLPRUVA | sodium phenylbutyrate |
| 72542-667 | OLPRUVA | sodium phenylbutyrate |
| 75987-060 | BUPHENYL | sodium phenylbutyrate |
| 75987-070 | Buphenyl | sodium phenylbutyrate |
| 71770-100 | PHEBURANE | Sodium phenylbutyrate |
| 71770-200 | PHEBURANE | Sodium phenylbutyrate |
| 71770-210 | PHEBURANE | Sodium phenylbutyrate |
| 42794-086 | Sodium Phenylbutyrate | Sodium Phenylbutyrate |
| 49884-006 | Sodium Phenylbutyrate | Sodium Phenylbutyrate |
| 68462-853 | sodium phenylbutyrate | sodium phenylbutyrate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OLPRUVA 88814846 not registered Live/Pending |
Acer Therapeutics Inc. 2020-02-28 |